2012-10-04 08:05:21 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Market Direct's pharmaceuticals report, "Alba Therapeutics Corporation - Product Pipeline Review - 2012" provides data on the Alba Therapeutics Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Alba Therapeutics Corporation's corporate website, SEC filings, investor presentations and featured press releases, both from Alba Therapeutics Corporation and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Alba Therapeutics Corporation - Brief Alba Therapeutics Corporation overview including business description, key information and facts, and its locations and subsidiaries.
* Review of

current pipeline of Alba Therapeutics Corporation human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Alba Therapeutics Corporation with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Alba Therapeutics Corporation's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468626_alba_therapeutics_corporation_product ..


Reasons to buy

* Evaluate Alba Therapeutics Corporation's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Alba Therapeutics Corporation in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Alba Therapeutics Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Alba Therapeutics Corporation.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Alba Therapeutics Corporation and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Alba Therapeutics Corporation Snapshot
Alba Therapeutics Corporation Overview
Key Information
Key Facts
Alba Therapeutics Corporation - Research and Development Overview
Key Therapeutic Areas
Alba Therapeutics Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Alba Therapeutics Corporation - Pipeline Products Glance
Alba Therapeutics Corporation Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Alba Therapeutics Corporation - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Alba Therapeutics Corporation - Drug Profiles
AT-1004 Vaccine Adjuvants
Product Description
Mechanism of Action
R&D Progress
AT-1005
Product Description
Mechanism of Action
R&D Progress
larazotide acetate
Product Description
Mechanism of Action
R&D Progress
Alba Therapeutics Corporation - Pipeline Products by Route of Administration
Alba Therapeutics Corporation - Pipeline Products By Mechanism of Action
Alba Therapeutics Corporation - Recent Pipeline Updates
Alba Therapeutics Corporation - Locations And Subsidiaries
Head Office
Alba Therapeutics Corporation, Recent Developments
Alba Therapeutics Corporation- Press Release
May 01, 2012: Alba Gains Exclusive Rights To Patient Reported Outcome Questionnaire For Patients With Celiac Disease
Mar 17, 2009: Alba Therapeutics Corporation Announces the Next Clinical Trial of its Lead Compound, Larazotide Acetate
Financial Deals Landscape
Alba Therapeutics Corporation, Deals Summary
Alba Therapeutics Corporation, Pharmaceuticals & Healthcare, Deal Details
Venture Financing
Alba Therapeutics Secures $10 Million In Venture Financing
Licensing Agreements
Shire Enters Into Licensing Agreement With Alba Therapeutics
Asset Transactions
Cephalon To Acquire Assets Related To Larazotide Acetate From Alba Therapeutics
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Alba Therapeutics Corporation, Key Information
Alba Therapeutics Corporation, Key Facts
Alba Therapeutics Corporation - Pipeline by Indication, 2012
Alba Therapeutics Corporation - Pipeline by Stage of Development, 2012
Alba Therapeutics Corporation - Monotherapy Products in Pipeline, 2012
Alba Therapeutics Corporation - Phase II, 2012
Alba Therapeutics Corporation - Phase I, 2012
Alba Therapeutics Corporation - Pre-Clinical, 2012
Alba Therapeutics Corporation - Discovery, 2012
Alba Therapeutics Corporation - Pipeline By Route of Administration, 2012
Alba Therapeutics Corporation - Pipeline Products By Mechanism of Action, 2012
Alba Therapeutics Corporation - Recent Pipeline Updates, 2012
Alba Therapeutics Corporation, Deals Summary
Alba Therapeutics Secures $10 Million In Venture Financing
Shire Enters Into Licensing Agreement With Alba Therapeutics
Cephalon To Acquire Assets Related To Larazotide Acetate From Alba Therapeutics

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468626&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.